 | • レポートコード：QYR2104Z0416 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、鎮痙薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗ムスカリン薬、平滑筋弛緩薬）、用途別市場規模（オフラインチャネル、オンラインチャネル）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鎮痙薬の市場動向 ・企業の競争状況、市場シェア ・鎮痙薬の種類別市場規模（抗ムスカリン薬、平滑筋弛緩薬） ・鎮痙薬の用途別市場規模（オフラインチャネル、オンラインチャネル） ・鎮痙薬の北米市場規模2016-2027（アメリカ、カナダ） ・鎮痙薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鎮痙薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鎮痙薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・鎮痙薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Allergan、Ipsen、Teva Pharmaceuticals、Novartis、Johnson & Johnson、Takeda Pharmaceutical、Sun Pharmaceutical Industries、Merz Pharma、Mylan、Fresenius Kabi、Endo International、Daewoong Pharmaceutical、Acorda Therapeutics、SteriMax、Emcure Pharmaceuticals、Sawai Pharmaceutical、Orient Pharma） ・結論 |
Antispasmodic drugs such as dicyclomine (Bentyl) and hyoscyamine (Levsin) relieve the stomach cramps brought on by IBS by relaxing the smooth muscle of the gut. They also may cause constipation, so they aren’t usually prescribed for people who suffer from IBS-C. Other side effects are dry mouth, drowsiness, and blurred vision.
Market Analysis and Insights: Global Anti-spasmodic Drugs Market
The global Anti-spasmodic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-spasmodic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-spasmodic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-spasmodic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-spasmodic Drugs market.
Global Anti-spasmodic Drugs Scope and Market Size
Anti-spasmodic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-spasmodic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antimuscarinics
Smooth Muscle Relaxants
Segment by Application
Offline Channel
Online Channel
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Allergan
Ipsen
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
SteriMax
Emcure Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-spasmodic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antimuscarinics
1.2.3 Smooth Muscle Relaxants
1.3 Market by Application
1.3.1 Global Anti-spasmodic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-spasmodic Drugs Market Perspective (2016-2027)
2.2 Anti-spasmodic Drugs Growth Trends by Regions
2.2.1 Anti-spasmodic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-spasmodic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anti-spasmodic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anti-spasmodic Drugs Industry Dynamic
2.3.1 Anti-spasmodic Drugs Market Trends
2.3.2 Anti-spasmodic Drugs Market Drivers
2.3.3 Anti-spasmodic Drugs Market Challenges
2.3.4 Anti-spasmodic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-spasmodic Drugs Players by Revenue
3.1.1 Global Top Anti-spasmodic Drugs Players by Revenue (2016-2021)
3.1.2 Global Anti-spasmodic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anti-spasmodic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-spasmodic Drugs Revenue
3.4 Global Anti-spasmodic Drugs Market Concentration Ratio
3.4.1 Global Anti-spasmodic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-spasmodic Drugs Revenue in 2020
3.5 Anti-spasmodic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-spasmodic Drugs Product Solution and Service
3.7 Date of Enter into Anti-spasmodic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-spasmodic Drugs Breakdown Data by Type
4.1 Global Anti-spasmodic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anti-spasmodic Drugs Forecasted Market Size by Type (2022-2027)
5 Anti-spasmodic Drugs Breakdown Data by Application
5.1 Global Anti-spasmodic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anti-spasmodic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-spasmodic Drugs Market Size (2016-2027)
6.2 North America Anti-spasmodic Drugs Market Size by Type
6.2.1 North America Anti-spasmodic Drugs Market Size by Type (2016-2021)
6.2.2 North America Anti-spasmodic Drugs Market Size by Type (2022-2027)
6.2.3 North America Anti-spasmodic Drugs Market Size by Type (2016-2027)
6.3 North America Anti-spasmodic Drugs Market Size by Application
6.3.1 North America Anti-spasmodic Drugs Market Size by Application (2016-2021)
6.3.2 North America Anti-spasmodic Drugs Market Size by Application (2022-2027)
6.3.3 North America Anti-spasmodic Drugs Market Size by Application (2016-2027)
6.4 North America Anti-spasmodic Drugs Market Size by Country
6.4.1 North America Anti-spasmodic Drugs Market Size by Country (2016-2021)
6.4.2 North America Anti-spasmodic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anti-spasmodic Drugs Market Size (2016-2027)
7.2 Europe Anti-spasmodic Drugs Market Size by Type
7.2.1 Europe Anti-spasmodic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anti-spasmodic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anti-spasmodic Drugs Market Size by Type (2016-2027)
7.3 Europe Anti-spasmodic Drugs Market Size by Application
7.3.1 Europe Anti-spasmodic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anti-spasmodic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anti-spasmodic Drugs Market Size by Application (2016-2027)
7.4 Europe Anti-spasmodic Drugs Market Size by Country
7.4.1 Europe Anti-spasmodic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anti-spasmodic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-spasmodic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anti-spasmodic Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-spasmodic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-spasmodic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-spasmodic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-spasmodic Drugs Market Size by Application
8.3.1 Asia-Pacific Anti-spasmodic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-spasmodic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-spasmodic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-spasmodic Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-spasmodic Drugs Market Size (2016-2027)
9.2 Latin America Anti-spasmodic Drugs Market Size by Type
9.2.1 Latin America Anti-spasmodic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anti-spasmodic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anti-spasmodic Drugs Market Size by Type (2016-2027)
9.3 Latin America Anti-spasmodic Drugs Market Size by Application
9.3.1 Latin America Anti-spasmodic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anti-spasmodic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anti-spasmodic Drugs Market Size by Application (2016-2027)
9.4 Latin America Anti-spasmodic Drugs Market Size by Country
9.4.1 Latin America Anti-spasmodic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anti-spasmodic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-spasmodic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anti-spasmodic Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-spasmodic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-spasmodic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-spasmodic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-spasmodic Drugs Market Size by Application
10.3.1 Middle East & Africa Anti-spasmodic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-spasmodic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-spasmodic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-spasmodic Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anti-spasmodic Drugs Introduction
11.1.4 Pfizer Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Anti-spasmodic Drugs Introduction
11.2.4 Allergan Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Ipsen
11.3.1 Ipsen Company Details
11.3.2 Ipsen Business Overview
11.3.3 Ipsen Anti-spasmodic Drugs Introduction
11.3.4 Ipsen Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.3.5 Ipsen Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Anti-spasmodic Drugs Introduction
11.4.4 Teva Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Anti-spasmodic Drugs Introduction
11.5.4 Novartis Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Anti-spasmodic Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Anti-spasmodic Drugs Introduction
11.7.4 Takeda Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Details
11.8.2 Sun Pharmaceutical Industries Business Overview
11.8.3 Sun Pharmaceutical Industries Anti-spasmodic Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.8.5 Sun Pharmaceutical Industries Recent Development
11.9 Merz Pharma
11.9.1 Merz Pharma Company Details
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Anti-spasmodic Drugs Introduction
11.9.4 Merz Pharma Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.9.5 Merz Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Anti-spasmodic Drugs Introduction
11.10.4 Mylan Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Details
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Anti-spasmodic Drugs Introduction
11.11.4 Fresenius Kabi Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.11.5 Fresenius Kabi Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Anti-spasmodic Drugs Introduction
11.12.4 Endo International Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.12.5 Endo International Recent Development
11.13 Daewoong Pharmaceutical
11.13.1 Daewoong Pharmaceutical Company Details
11.13.2 Daewoong Pharmaceutical Business Overview
11.13.3 Daewoong Pharmaceutical Anti-spasmodic Drugs Introduction
11.13.4 Daewoong Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.13.5 Daewoong Pharmaceutical Recent Development
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Details
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Anti-spasmodic Drugs Introduction
11.14.4 Acorda Therapeutics Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.14.5 Acorda Therapeutics Recent Development
11.15 SteriMax
11.15.1 SteriMax Company Details
11.15.2 SteriMax Business Overview
11.15.3 SteriMax Anti-spasmodic Drugs Introduction
11.15.4 SteriMax Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.15.5 SteriMax Recent Development
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Details
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Anti-spasmodic Drugs Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.16.5 Emcure Pharmaceuticals Recent Development
11.17 Sawai Pharmaceutical
11.17.1 Sawai Pharmaceutical Company Details
11.17.2 Sawai Pharmaceutical Business Overview
11.17.3 Sawai Pharmaceutical Anti-spasmodic Drugs Introduction
11.17.4 Sawai Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.17.5 Sawai Pharmaceutical Recent Development
11.18 Orient Pharma
11.18.1 Orient Pharma Company Details
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Anti-spasmodic Drugs Introduction
11.18.4 Orient Pharma Revenue in Anti-spasmodic Drugs Business (2016-2021)
11.18.5 Orient Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-spasmodic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antimuscarinics
Table 3. Key Players of Smooth Muscle Relaxants
Table 4. Global Anti-spasmodic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-spasmodic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-spasmodic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti-spasmodic Drugs Market Share by Regions (2016-2021)
Table 8. Global Anti-spasmodic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti-spasmodic Drugs Market Share by Regions (2022-2027)
Table 10. Anti-spasmodic Drugs Market Trends
Table 11. Anti-spasmodic Drugs Market Drivers
Table 12. Anti-spasmodic Drugs Market Challenges
Table 13. Anti-spasmodic Drugs Market Restraints
Table 14. Global Anti-spasmodic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti-spasmodic Drugs Market Share by Players (2016-2021)
Table 16. Global Top Anti-spasmodic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-spasmodic Drugs as of 2020)
Table 17. Ranking of Global Top Anti-spasmodic Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti-spasmodic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-spasmodic Drugs Product Solution and Service
Table 21. Date of Enter into Anti-spasmodic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti-spasmodic Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Anti-spasmodic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti-spasmodic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti-spasmodic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti-spasmodic Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Anti-spasmodic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti-spasmodic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti-spasmodic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti-spasmodic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti-spasmodic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-spasmodic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti-spasmodic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti-spasmodic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti-spasmodic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti-spasmodic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti-spasmodic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti-spasmodic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti-spasmodic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-spasmodic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-spasmodic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti-spasmodic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti-spasmodic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti-spasmodic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti-spasmodic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti-spasmodic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti-spasmodic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti-spasmodic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-spasmodic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-spasmodic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Anti-spasmodic Drugs Product
Table 64. Pfizer Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Anti-spasmodic Drugs Product
Table 69. Allergan Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Ipsen Company Details
Table 72. Ipsen Business Overview
Table 73. Ipsen Anti-spasmodic Drugs Product
Table 74. Ipsen Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 75. Ipsen Recent Development
Table 76. Teva Pharmaceuticals Company Details
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Anti-spasmodic Drugs Product
Table 79. Teva Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Anti-spasmodic Drugs Product
Table 84. Novartis Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Anti-spasmodic Drugs Product
Table 89. Johnson & Johnson Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Takeda Pharmaceutical Company Details
Table 92. Takeda Pharmaceutical Business Overview
Table 93. Takeda Pharmaceutical Anti-spasmodic Drugs Product
Table 94. Takeda Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 95. Takeda Pharmaceutical Recent Development
Table 96. Sun Pharmaceutical Industries Company Details
Table 97. Sun Pharmaceutical Industries Business Overview
Table 98. Sun Pharmaceutical Industries Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 99. Sun Pharmaceutical Industries Recent Development
Table 100. Merz Pharma Company Details
Table 101. Merz Pharma Business Overview
Table 102. Merz Pharma Anti-spasmodic Drugs Product
Table 103. Merz Pharma Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 104. Merz Pharma Recent Development
Table 105. Mylan Company Details
Table 106. Mylan Business Overview
Table 107. Mylan Anti-spasmodic Drugs Product
Table 108. Mylan Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Fresenius Kabi Company Details
Table 111. Fresenius Kabi Business Overview
Table 112. Fresenius Kabi Anti-spasmodic Drugs Product
Table 113. Fresenius Kabi Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 114. Fresenius Kabi Recent Development
Table 115. Endo International Company Details
Table 116. Endo International Business Overview
Table 117. Endo International Anti-spasmodic Drugs Product
Table 118. Endo International Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 119. Endo International Recent Development
Table 120. Daewoong Pharmaceutical Company Details
Table 121. Daewoong Pharmaceutical Business Overview
Table 122. Daewoong Pharmaceutical Anti-spasmodic Drugs Product
Table 123. Daewoong Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 124. Daewoong Pharmaceutical Recent Development
Table 125. Acorda Therapeutics Company Details
Table 126. Acorda Therapeutics Business Overview
Table 127. Acorda Therapeutics Anti-spasmodic Drugs Product
Table 128. Acorda Therapeutics Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 129. Acorda Therapeutics Recent Development
Table 130. SteriMax Company Details
Table 131. SteriMax Business Overview
Table 132. SteriMax Anti-spasmodic Drugs Product
Table 133. SteriMax Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 134. SteriMax Recent Development
Table 135. Emcure Pharmaceuticals Company Details
Table 136. Emcure Pharmaceuticals Business Overview
Table 137. Emcure Pharmaceuticals Anti-spasmodic Drugs Product
Table 138. Emcure Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 139. Emcure Pharmaceuticals Recent Development
Table 140. Sawai Pharmaceutical Company Details
Table 141. Sawai Pharmaceutical Business Overview
Table 142. Sawai Pharmaceutical Anti-spasmodic Drugs Product
Table 143. Sawai Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 144. Sawai Pharmaceutical Recent Development
Table 145. Orient Pharma Company Details
Table 146. Orient Pharma Business Overview
Table 147. Orient Pharma Anti-spasmodic Drugs Product
Table 148. Orient Pharma Revenue in Anti-spasmodic Drugs Business (2016-2021) & (US$ Million)
Table 149. Orient Pharma Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-spasmodic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antimuscarinics Features
Figure 3. Smooth Muscle Relaxants Features
Figure 4. Global Anti-spasmodic Drugs Market Share by Application: 2020 VS 2027
Figure 5. Offline Channel Case Studies
Figure 6. Online Channel Case Studies
Figure 7. Anti-spasmodic Drugs Report Years Considered
Figure 8. Global Anti-spasmodic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti-spasmodic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-spasmodic Drugs Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti-spasmodic Drugs Market Share by Regions (2022-2027)
Figure 12. Global Anti-spasmodic Drugs Market Share by Players in 2020
Figure 13. Global Top Anti-spasmodic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-spasmodic Drugs as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti-spasmodic Drugs Revenue in 2020
Figure 15. Global Anti-spasmodic Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti-spasmodic Drugs Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti-spasmodic Drugs Market Share by Type (2016-2027)
Figure 19. North America Anti-spasmodic Drugs Market Share by Application (2016-2027)
Figure 20. North America Anti-spasmodic Drugs Market Share by Country (2016-2027)
Figure 21. United States Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti-spasmodic Drugs Market Share by Type (2016-2027)
Figure 25. Europe Anti-spasmodic Drugs Market Share by Application (2016-2027)
Figure 26. Europe Anti-spasmodic Drugs Market Share by Country (2016-2027)
Figure 27. Germany Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti-spasmodic Drugs Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti-spasmodic Drugs Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti-spasmodic Drugs Market Share by Region (2016-2027)
Figure 37. China Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti-spasmodic Drugs Market Share by Type (2016-2027)
Figure 45. Latin America Anti-spasmodic Drugs Market Share by Application (2016-2027)
Figure 46. Latin America Anti-spasmodic Drugs Market Share by Country (2016-2027)
Figure 47. Mexico Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti-spasmodic Drugs Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti-spasmodic Drugs Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti-spasmodic Drugs Market Share by Country (2016-2027)
Figure 53. Turkey Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti-spasmodic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 57. Allergan Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 58. Ipsen Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 59. Teva Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 64. Merz Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 67. Endo International Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 68. Daewoong Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 69. Acorda Therapeutics Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 70. SteriMax Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 71. Emcure Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 72. Sawai Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 73. Orient Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の抗真菌薬市場規模・現状・予測（2021年-2027年） Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails. Market Analysis and Insights: Global Anti-fungal Drugs Market The global Anti-fungal Drugs market size is projected to reach US$ 2048.7 million by 2026, from US$ 1728.4 million in 2019, at a C…
- 世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…